Seth Corey, MD
Pediatric Benign Hematology
Highlights
Age Groups Seen
- Child
- Adolescent
Languages
- English
Gender
MaleAbout Seth Corey
Biography
Professor of Molecular Medicine and Staff.
Yale BA; Tulane MD, MPH; Residency in Pediatrics St Louis Children's Hosp/Washington Univ School of Medicine; Fellowship in Pediatric Hematology/Oncology Boston Children's Hospital/Dana-Farber Cancer Institute/Harvard Medical School; post-doctoral fellowship Harvard Medical School and Tufts Univ School of Medicine.
Grant reviewer for National Institutes of Health, American Society for Hematology, Alex's Lemonade Stand Foundation, American Heart Association, Leukemia and Lymphoma Society
Editorial Board for eLife,Frontiers in Pediatrics,
Scientific Advisory Board, Shachman-Diamond Syndrome Foundation
Leadership Training, MD Anderson Cancer Center
Locations
- Cleveland Clinic Children's Outpatient Center
- 8950 Euclid Avenue, Cleveland, OH 44106
- Get Directions
Education & Board Certifications
Education
- Fellowship: Boston Children's Hospital, 1988
- Residency: Saint Louis Children's Hospital, 1985
- Internship: Saint Louis Children's Hospital, 1983
- Medical Education: Tulane University School of Medicine, 1982
- Graduate School: Tulane University School of Public Health and Tropical Medicine, 1982
- Undergraduate: Yale University, 1978
Board Certifications
- Pediatric Hematology-Oncology: American Board of Pediatrics, 2004
Awards
NIH First Award; NIH Independent Scientist Award, NIH R01 Investigator, DOD Rare Cancer, DOD Bone Marrow Failure,
Top Doctor for Cancer 2005, Top Doctor (Pediatric Hematology/Oncology 2010-2015
Innovations & Patents
Animal models of inherited bone marrow failure syndromes, Barth syndrome, and Ewing sarcoma
Research & Publications
See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.
As of 2026-04-08, Dr. Corey has reported no financial relationship with industry that is applicable to this listing.
In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.